title: Effects of serotonin and serotonergic agonists and antagonists on the production of interferon-gamma and interleukin-10.
abstract: Serotonin (5-HT) is a neurotransmitter and an immune modulator. In vitro, antidepressants with a serotonergic mode of action have, at concentrations within the therapeutical range, negative immunoregulatory effects, i.e., they increase the production rate of interleukin-10 (IL-10), a negative immunoregulatory cytokine. We have hypothesized that part of these effects may be explained by the serotonergic activities of antidepressants on immunocytes. This study was carried out to examine the effects of 5-HT, p-chlorophenylalanine (PCPA), a 5-HT depleting agent, flesinoxan (a 5-HT1A agonist), m-chlorophenylpiperazine (mCPP; a 5-HT2A/2C agonist), and ritanserin (a 5-HT2A/2C antagonist) on the production rate of interferon-gamma (IFNgamma), a proinflammatory cytokine, and IL-10 by whole blood stimulated with polyclonal activators. The IFNgamma/IL-10 production ratio was computed, since this ratio reflects the pro- versus anti-inflammatory capacity of cultured whole blood. We found that: 1) 5-HT, 150 ng/mL, 1.5 microg/mL, and 15 microg/mL significantly decreased the IFNgamma/IL-10 ratio; 2) PCPA (5 microM) significantly suppressed the production of IFNgamma and IL-10; 3) flesinoxan (15 ng/mL; 1.5 microg/mL) had no significant effects on the production of the above cytokines; and 4) mCPP (2.7 microg/mL) and ritanserin (5.0 microg/mL) suppressed the IFNgamma/IL-10 ratio. It is concluded that intracellular 5-HT may be necessary for an optimal synthesis of IFNgamma and IL-10, and that extracellular 5-HT concentrations at or above serum values may suppress the production of the proinflammatory cytokine IFNgamma. The negative immunoregulatory effects of antidepressive drugs are probably not related to their serotonergic activities.
authors.affiliation: Clinical Research Center for Mental Health, Anwerp, Belgium.
authors.forename: M
authors.initials: M
authors.lastname: Kubera
authors.forename: G
authors.initials: G
authors.lastname: Kenis
authors.forename: E
authors.initials: E
authors.lastname: Bosmans
authors.forename: S
authors.initials: S
authors.lastname: Scharpé
authors.forename: M
authors.initials: M
authors.lastname: Maes
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D005260:Female; D016166:Free Radical Scavengers / Q000494:pharmacology*; D006801:Humans; D007371:Interferon-gamma / Q000097:blood / Q000187:drug effects*; D016753:Interleukin-10 / Q000097:blood; D008297:Male; D008875:Middle Aged; D012701:Serotonin / Q000494:pharmacology*; D012702:Serotonin Antagonists / Q000494:pharmacology*; D017366:Serotonin Receptor Agonists / Q000494:pharmacology*
chemical_list: D016166:Free Radical Scavengers; D012702:Serotonin Antagonists; D017366:Serotonin Receptor Agonists; D016753:Interleukin-10; D012701:Serotonin; D007371:Interferon-gamma